Literature DB >> 282070

Haemodynamic effects of a calcium antagonistic agent (nifedipine) in hypertension: therapeutic implications.

C Bartorelli, F Magrini, P Moruzzi, M T Olivari, A Polese, C Fiorentini, M Guazzi.   

Abstract

1. In 27 severe primary hypertensive patients nifedipine (10 mg), administered orally, induced prompt (-21% of control at 30 min) and persistent (-17% at 120 min) fall of mean arterial pressure mediated through reduction of peripheral vascular resistance with rise of cardiac output. 2. The sublingual route (nine cases) showed more rapid onset of action and equal antihypertensive effectiveness. 3. In five patients with hypertensive crisis and acute left ventricular failure, the drug strikingly reduced systemic and pulmonary arterial pressures and relieved pulmonary oedema. 4. Prompt efficacy, ease of administration, absence of important side effects indicate that nifedipine may be a useful therapeutic agent in severe hypertension and in critical conditions that require rapid lowering of blood pressure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 282070     DOI: 10.1042/cs055291s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  10 in total

1.  Pharmacokinetics of nifedipine derived from a new retard tablet formulation.

Authors:  A Avgerinos; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

3.  Blockade of slow calcium channels and regulation of circulatory pressor responses in uncomplicated hypertension.

Authors:  B Silke; R C Ahuja; R C Okoli; G I Nelson; S H Taylor
Journal:  Ir J Med Sci       Date:  1983-10       Impact factor: 1.568

Review 4.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

5.  Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension.

Authors:  M Thibonnier; F Bonnet; P Corvol
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

Review 6.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

Review 7.  Treatment of severe hypertension and hypertensive crises with nifedipine.

Authors:  M C Houston
Journal:  West J Med       Date:  1987-06

8.  Efficacy of nifedipine in the treatment of angina pectoris and chronic airways obstruction.

Authors:  S S Jaiprakash; J N Sahay; S S Chatterjee; G MacDonald
Journal:  Postgrad Med J       Date:  1980-09       Impact factor: 2.401

9.  Nifedipine in the treatment of difficult hypertensives.

Authors:  S Dean; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 10.  [Calcium antagonists in the therapy of hypertension].

Authors:  A Heidland; E Heidbreder; W H Hörl; R M Schäfer
Journal:  Klin Wochenschr       Date:  1983-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.